These changes are related to inhibition of TNF-α due to the presence of PPAR-α and NF-κB in favorable metabolic adaptive responses, inhibiting apoptosis and contributing to the improvement of post-MI ventricular performance. The gene discussed is NFKB1; the disease is myocardial infarction.